Researchers at Tel Aviv University have developed an effective, inexpensive, and simple COVID-19 vaccine that can be stored at room temperature and administered as a nasal spray Prof. Ronit Satchi ...

The FDA has approved FluMist, a nasal spray flu vaccine, for self-administration. Healthy individuals aged 2 to 49 can use ...

A Tsinghua University team has designed a vaccine to be administered directly into the nasal cavity, which helped to induce sustained and protective immune responses from SARS-CoV-2 virus variants ...

Intranasal vaccines, which can elicit both mucosal and systemic immune responses, are delivered through the nasal cavity, most commonly by an aerosolized spray, although nasally administered drops, ...

British pharmaceutical company AstraZeneca (AZ) has developed a nasal spray flu vaccine named "FluMist." It was initially approved for medical institutions in 2003, and in October of last year ...

Nasal vaccines could still be a powerful weapon in the fight against Covid-19 despite “disappointing” recent trial results for an AstraZeneca spray, experts say. By entering the body the same ...

Just a few months after starting clinical trials of its nasal spray vaccine for COVID-19, US biotech Altimmune is abandoning the project, saying that it generated weaker than expected immune ...

With some wondering when Western nations would catch up, last week Oxford researchers revealed the results of a phase 1 trial for a simple nasal spray using the AstraZeneca vaccine. However ...

Several mucosal vaccine candidates are being explored in pre-clinical and clinical trials. Results just published on a nasal booster vaccine in mice showed that robust mucosal immune responses were ...

Here’s how it would work: A nasal mRNA vaccine would be taken as a spray through the nose, coating the nasal passages. The cells in the nasal lining would use the vaccine’s instructions to ...

And they're trying to come up with ways of delivery, whether it's drops or whether it's a nasal spray. So these are some of the questions that remain to be answered. AL-GHALIB: So this vaccine is ...